Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 454

1.

Procoagulant imbalance influences cardiovascular and liver damage in chronic hepatitis C independently of steatosis.

Sigon G, D'Ambrosio R, Clerici M, Pisano G, Chantarangkul V, Sollazzi R, Lombardi R, Peyvandi F, Lampertico P, Fargion S, Tripodi A, Fracanzani AL.

Liver Int. 2019 Aug 16. doi: 10.1111/liv.14213. [Epub ahead of print]

PMID:
31419372
2.

Real-life experience in switching to new extended half-life products at European haemophilia centres.

Peyvandi F, Garagiola I, Boscarino M, Ryan A, Hermans C, Makris M.

Haemophilia. 2019 Aug 16. doi: 10.1111/hae.13834. [Epub ahead of print]

PMID:
31418967
3.

Prevalence of use and appropriateness of antidepressants prescription in acutely hospitalized elderly patients.

Carlotta F, Raffaella R, Ilaria A, Alessandro N, Mannuccio MP; REPOSI Collaborators.

Eur J Intern Med. 2019 Aug 9. pii: S0953-6205(19)30258-4. doi: 10.1016/j.ejim.2019.07.025. [Epub ahead of print] No abstract available.

PMID:
31405773
4.

International Society on Thrombosis and Haemostasis core curriculum project: core competencies in laboratory thrombosis and hemostasis.

Moffat KA, Kiencke V, Blanco AN, McLintock C, Peyvandi F, de Maat MPM, Adams MJ, Angchaisuksiri P, Nair S, Tsuda H, Haddad M, Renné T, Clark RC, Ross MT.

J Thromb Haemost. 2019 Aug 9. doi: 10.1111/jth.14601. [Epub ahead of print]

PMID:
31400072
5.

Profiling the mutational landscape of coagulation factor V deficiency.

Paraboschi EM, Menegatti M, Rimoldi V, Borhany M, Abdelwahab M, Gemmati D, Peyvandi F, Duga S, Asselta R.

Haematologica. 2019 Aug 8. pii: haematol.2019.232587. doi: 10.3324/haematol.2019.232587. [Epub ahead of print]

6.

Phase 3 study of recombinant von Willebrand factor in patients with severe von Willebrand disease who are undergoing elective surgery: Reply.

Peyvandi F.

J Thromb Haemost. 2019 Aug;17(8):1405-1406. doi: 10.1111/jth.14545. No abstract available.

PMID:
31368219
7.

How we make an accurate diagnosis of von Willebrand disease.

Baronciani L, Peyvandi F.

Thromb Res. 2019 Jul 16. pii: S0049-3848(19)30293-2. doi: 10.1016/j.thromres.2019.07.010. [Epub ahead of print] Review.

PMID:
31353031
8.

Burden of mild haemophilia A: Systematic literature review.

Peyvandi F, Tavakkoli F, Frame D, Quinn J, Kim B, Lawal A, Lee MC, Wong WY.

Haemophilia. 2019 Jul 11. doi: 10.1111/hae.13777. [Epub ahead of print]

PMID:
31294906
9.

Clinical advances in gene therapy updates on clinical trials of gene therapy in haemophilia.

Peyvandi F, Garagiola I.

Haemophilia. 2019 Jul 8. doi: 10.1111/hae.13816. [Epub ahead of print] Review.

PMID:
31282050
10.

Molecular Aggregation of Marketed Recombinant FVIII Products: Biochemical Evidence and Functional Effects.

De Cristofaro R, Sacco M, Lancellotti S, Berruti F, Garagiola I, Valsecchi C, Basso M, Di Stasio E, Peyvandi F.

TH Open. 2019 May 8;3(2):e123-e131. doi: 10.1055/s-0039-1688413. eCollection 2019 Apr.

11.

Evolution of replacement therapy for von Willebrand disease: From plasma fraction to recombinant von Willebrand factor.

Peyvandi F, Kouides P, Turecek PL, Dow E, Berntorp E.

Blood Rev. 2019 Apr 3. pii: S0268-960X(18)30015-8. doi: 10.1016/j.blre.2019.04.001. [Epub ahead of print] Review.

12.

Analysis of factor V in zebrafish demonstrates minimal levels needed for early hemostasis.

Weyand AC, Grzegorski SJ, Rost MS, Lavik KI, Ferguson AC, Menegatti M, Richter CE, Asselta R, Duga S, Peyvandi F, Shavit JA.

Blood Adv. 2019 Jun 11;3(11):1670-1680. doi: 10.1182/bloodadvances.2018029066.

13.

Design of a prospective observational study on the effectiveness and real-world usage of recombinant factor VIII Fc (rFVIIIFc) compared with conventional products in haemophilia A: the A-SURE study.

Oldenburg J, Hay CRM, Jiménez-Yuste V, Peyvandi F, Schved JF, Szamosi J, Winding B, Lethagen S.

BMJ Open. 2019 May 30;9(5):e028012. doi: 10.1136/bmjopen-2018-028012.

14.

Evaluation of an automated chromogenic assay for Factor VIII clotting activity measurement in patients affected by haemophilia A.

Novembrino C, Boscolo Anzoletti M, Mancuso ME, Shinohara S, Peyvandi F.

Haemophilia. 2019 May;25(3):521-526. doi: 10.1111/hae.13746. Epub 2019 May 2.

PMID:
31044485
15.

Consensus statements on vaccination in patients with haemophilia-Results from the Italian haemophilia and vaccinations (HEVA) project.

Santagostino E, Riva A, Cesaro S, Esposito S, Matino D, Mazzucchelli RI, Molinari AC, Mura R, Notarangelo LD, Tagliaferri A, Di Minno G, Clerici M; the HEVA Study Group.

Haemophilia. 2019 Jul;25(4):656-667. doi: 10.1111/hae.13756. Epub 2019 Apr 16.

PMID:
30990961
16.

Rescue factor VIII replacement to secure hemostasis in a patient with hemophilia A and inhibitors on emicizumab prophylaxis undergoing hip replacement.

Santagostino E, Mancuso ME, Novembrino C, Solimeno LP, Tripodi A, Peyvandi F.

Haematologica. 2019 Aug;104(8):e380-e382. doi: 10.3324/haematol.2018.215129. Epub 2019 Mar 28. No abstract available.

17.

Clinical and Laboratory Features of Patients with Acquired Thrombotic Thrombocytopenic Purpura: Fourteen Years of the Milan TTP Registry.

Mancini I, Pontiggia S, Palla R, Artoni A, Valsecchi C, Ferrari B, Mikovic D, Peyvandi F; Italian Group of TTP Investigators.

Thromb Haemost. 2019 May;119(5):695-704. doi: 10.1055/s-0039-1679907. Epub 2019 Mar 12.

PMID:
30861548
18.

Hospital Care of Older Patients With COPD: Adherence to International Guidelines for Use of Inhaled Bronchodilators and Corticosteroids.

Proietti M, Agosti P, Lonati C, Corrao S, Perticone F, Mannucci PM, Nobili A, Harari S; REPOSI Investigators.

J Am Med Dir Assoc. 2019 Mar 6. pii: S1525-8610(19)30159-8. doi: 10.1016/j.jamda.2019.01.132. [Epub ahead of print]

PMID:
30852169
19.

Hypercoagulability and the risk of recurrence in young women with myocardial infarction or ischaemic stroke: a cohort study.

Maino A, Algra A, Peyvandi F, Rosendaal FR, Siegerink B.

BMC Cardiovasc Disord. 2019 Mar 7;19(1):55. doi: 10.1186/s12872-019-1040-4.

20.

Complications of whole-exome sequencing for causal gene discovery in primary platelet secretion defects.

Gorski MM, Lecchi A, Femia EA, La Marca S, Cairo A, Pappalardo E, Lotta LA, Artoni A, Peyvandi F.

Haematologica. 2019 Feb 28. pii: haematol.2018.204990. doi: 10.3324/haematol.2018.204990. [Epub ahead of print]

Supplemental Content

Loading ...
Support Center